nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alternative fluorophores designed for advanced molecular imaging
|
Freidus, Lara G. |
|
2018 |
23 |
1 |
p. 115-133 |
artikel |
2 |
CHEMGENIE: integration of chemogenomics data for applications in chemical biology
|
Kutchukian, Peter S. |
|
2018 |
23 |
1 |
p. 151-160 |
artikel |
3 |
Contents page 1
|
|
|
2018 |
23 |
1 |
p. i |
artikel |
4 |
Contents page 2
|
|
|
2018 |
23 |
1 |
p. ii |
artikel |
5 |
Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe
|
Fregonese, Laura |
|
2018 |
23 |
1 |
p. 90-100 |
artikel |
6 |
3D nerve cell cultures and complex physiological relevance
|
Cheng, Xin |
|
2018 |
23 |
1 |
p. 22-25 |
artikel |
7 |
Drug discovery tomorrow: how to Catapult ourselves into the future
|
Molloy, Chris |
|
2018 |
23 |
1 |
p. 1-3 |
artikel |
8 |
Drug target residence time: a misleading concept
|
Folmer, Rutger H.A. |
|
2018 |
23 |
1 |
p. 12-16 |
artikel |
9 |
Finding hidden treasures in old drugs: the challenges and importance of licensing generics
|
Simsek, Melek |
|
2018 |
23 |
1 |
p. 17-21 |
artikel |
10 |
HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions
|
Ganjali, Shiva |
|
2018 |
23 |
1 |
p. 171-180 |
artikel |
11 |
Indacaterol/glycopyrronium: a dual bronchodilator for COPD
|
Banerji, Donald |
|
2018 |
23 |
1 |
p. 196-203 |
artikel |
12 |
Insights from pharmacological similarity of epigenetic targets in epipolypharmacology
|
Naveja, J. Jesús |
|
2018 |
23 |
1 |
p. 141-150 |
artikel |
13 |
Locked nucleic acid: modality, diversity, and drug discovery
|
Hagedorn, Peter H. |
|
2018 |
23 |
1 |
p. 101-114 |
artikel |
14 |
Molecular targets and pathways for the treatment of visceral leishmaniasis
|
Jain, Vineet |
|
2018 |
23 |
1 |
p. 161-170 |
artikel |
15 |
Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions
|
Sheean, Maria E. |
|
2018 |
23 |
1 |
p. 26-48 |
artikel |
16 |
One-size-fits-all dosing in oncology wastes money, innovation and lives
|
Norris, David C. |
|
2018 |
23 |
1 |
p. 4-6 |
artikel |
17 |
Overcoming or circumventing the stratum corneum barrier for efficient transcutaneous immunization
|
Chen, Zhongjian |
|
2018 |
23 |
1 |
p. 181-186 |
artikel |
18 |
Quantifying the allosteric interactions within a G-protein-coupled receptor heterodimer
|
Zhou, Bin |
|
2018 |
23 |
1 |
p. 7-11 |
artikel |
19 |
Rare genetic diseases: update on diagnosis, treatment and online resources
|
Pogue, Robert E. |
|
2018 |
23 |
1 |
p. 187-195 |
artikel |
20 |
Relict plastidic metabolic process as a potential therapeutic target
|
Sharma, Drista |
|
2018 |
23 |
1 |
p. 134-140 |
artikel |
21 |
Revisiting asthma therapeutics: focus on WNT signal transduction
|
Koopmans, Tim |
|
2018 |
23 |
1 |
p. 49-62 |
artikel |
22 |
Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors
|
Ramadoss, Mahalakshmi |
|
2018 |
23 |
1 |
p. 76-89 |
artikel |
23 |
Towards carborane-functionalised structures for the treatment of brain cancer
|
Calabrese, Gianpiero |
|
2018 |
23 |
1 |
p. 63-75 |
artikel |